Edouard W Khandjian Selected Research

Fragile X Mental Retardation Protein

1/2016	Tracking the Fragile X Mental Retardation Protein in a Highly Ordered Neuronal RiboNucleoParticles Population: A Link between Stalled Polyribosomes and RNA Granules.
10/2013	Nuclear Fragile X Mental Retardation Protein is localized to Cajal bodies.
1/2012	Fragile X mental retardation protein interacts with the RNA-binding protein Caprin1 in neuronal RiboNucleoProtein complexes [corrected].
1/2009	A novel function for fragile X mental retardation protein in translational activation.
1/2008	On BC1 RNA and the fragile X mental retardation protein.
12/2007	The fragile X mental retardation protein is a molecular adaptor between the neurospecific KIF3C kinesin and dendritic RNA granules.
1/2007	Fragile X related protein 1 isoforms differentially modulate the affinity of fragile X mental retardation protein for G-quartet RNA structure.
1/2005	Lost once, the Fragile X Mental Retardation protein is now back onto brain polyribosomes.
9/2004	Biochemical evidence for the association of fragile X mental retardation protein with brain polyribosomal ribonucleoparticles.
1/2004	The fragile X mental retardation protein has nucleic acid chaperone properties.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Edouard W Khandjian Research Topics

Disease

12	Fragile X Syndrome (Martin Bell Syndrome) 01/2016 - 11/2002
8	Intellectual Disability (Idiocy) 01/2016 - 11/2002
4	Neoplasms (Cancer) 01/2020 - 12/2015
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Insulin Resistance 01/2019
1	Autistic Disorder (Autism) 01/2016
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 02/2013
1	Inborn Genetic Diseases (Disease, Hereditary) 08/2008
1	Ganglion Cysts (Ganglion) 01/2003
1	Hypoxia (Hypoxemia) 01/2003

Drug/Important Bio-Agent (IBA)

11	RNA-Binding Proteins (RNA-Binding Protein)IBA 10/2017 - 11/2002
11	Fragile X Mental Retardation ProteinIBA 01/2016 - 11/2002
3	RNA (Ribonucleic Acid)IBA 01/2016 - 01/2007
3	Proteins (Proteins, Gene)FDA Link 01/2016 - 01/2008
2	Messenger RNA (mRNA)IBA 01/2016 - 01/2003
1	Lapatinib (GW572016)FDA Link 01/2020
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	LipidsIBA 01/2019
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2019
1	Sorafenib (BAY 43-9006)FDA Link 10/2017
1	Transcription Factors (Transcription Factor)IBA 10/2017
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	DNA (Deoxyribonucleic Acid)IBA 01/2016
1	Proteasome InhibitorsIBA 12/2015
1	Fluorouracil (Carac)FDA LinkGeneric 12/2015
1	Small Nuclear RNA (snRNA)IBA 02/2013
1	RibonucleoproteinsIBA 02/2013
1	Dopamine (Intropin)FDA LinkGeneric 01/2003